Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 13 of 13 for “"Combination product"”.
-
D-optimal design of a pediatric pharmacokinetic study of a fixed dose combination product of rifampicin-pyrazinamide-isoniazid for the treatment of tuberculosis
Ο σκοπός αυτής της εργασίας είναι να σχεδιαστεί μια παιδιατρική φαρμακοκινητική μελέτη αραιής δειγματοληψίας ενός φαρμακευτικού σκευάσματος σταθερού συνδυασμού δόσης, ισονιαζίδης, ριφαμπικίνης και πυραζιναμίδης για την θεραπεία της φυματίωσης. Θεωρείται ότι θα δοθεί μια μοναδική χορήγηση του …
-
Insecticide Resistance in the Bed Bug
… of resistance to pyrethroid and neonicotinoid combination products (called combination products here) and to a neonicotinoid in the laboratory, to record potential fitness costs to resistance to the combination products, and to compare the efficacy of nine insecticides on six populations. In …
-
Inhalative Kombinationspräparate durch Co-Präzipitation
In der vorliegenden Arbeit wird eine neue Methode zur Herstellung von Pulvern zur Inhalation beschrieben, die zwei Wirkstoffe beinhalten. Dabei handelt es sich um das langwirksame beta-2-Sympathomimetikum Salmeterolxinafoat und das Glucocorticoid Fluticasonpropionat. Beide Substanzen werden in der …
-
Fabrication and Evaluation of a Dual-Drug Loaded Immediate and Sustained Release Ophthalmic Inserts for the Management of Keratitis; Moxifloxacin and Voriconazole
… release for 6 hours, similar to that of the combination product. The ex vivo trans-corneal permeation studies were performed and compared against commercial MOX eye drops and VORI solution. The lower trans-corneal flux from the inserts for both drugs, compared to solution controls, is …
-
Utilizing spring dead spot mapping to assess precision management strategies, topographical epidemiology, economic opportunities
… a 10-year horizon when applying isofetamid or a combination product of pydiflumetofen + azoxystrobin + propiconazole. Conversely, this strategy was not cost-effective with annual applications of tebuconazole due to its low cost per application. These findings suggest that adopting precision …
-
Development of copper-flavonoid complexes for treatment of acute myeloid leukemia (AML)
… unchanged and reliant on chemotherapeutic drug combinations. Despite the approval of novel targeted therapies, broad-spectrum chemotherapy drugs have been used to address the genetic heterogeneity of AML. One class of broad-spectrum compounds called flavonoids has shown promise in the treatment …
-
Non steroidal anti-inflammatory drugs and cardiovascular risk: identifying evidence for channelling bias in a population based study
… was the only NSAID that could be obtained as a combination product (i.e., formulated with misoprostol). As a result, channelling bias might have resulted if prescribers selected the combination of diclofenac/misoprostol (Diclo-Miso) in patients with poor health status frequently than other NSAID …
-
Clinically relevant and economic outcomes of maintenance pharmacotherapy in chronic obstructive pulmonary disease (COPD)
… population between recipients treated with the combination product of ipratropium/albuterol versus inhaled long-acting beta-agonists. Phase II also showed that therapy with ICS either alone or in combination with an inhaled long-acting beta-agonist did not reduce the risk of a severe …
-
Mechanism of biomaterial adjuvant effect: Phenotype of dendritic cells upon biomaterial contact
Development of combination products such as tissue engineered constructs which combine biomaterials with biologics has prompted the need to clarify the role of biomaterial in potentiating the immune response towards the biological component due to adjuvant effect. In tissue engineering …
-
Engineering of Inhalation Aerosols Combining Theophylline and Budesonide
… This type of particle has the advantage over a combination product containing both drugs in a physical mixture which occurs rather randomly deposition leading to API segregation and non-dose-uniformity. Dry powder inhalers (DPIs) is a type of therapeutic pharmaceutical formulations usually …
-
Delineamento de biocompósitos baseados em paligorsquita e quitosana como carreadores de etambutol
… isoniazid, and pyrazinamide) as a fixed dose combination product, which leads to interaction and stability problems. Considering the difficulty found in this treatment, this work proposed to develop composites to carry the tuberculostatic ethambutol based on palygorskite, a fibrous clay …
-
Prescribing patterns of asthma treatment in the private healthcare sector of South Africa
… (n = 39 721) followed by the single item combination product of budesonide/ formoterol (n = 25 121) and salbutamol (n = 24 296). The influence of COPD on asthma treatment and the costimplication thereof were investigated. Medication from the MIMS® pharmacological group (anti-asthmatics and …
-
A preclinical evaluation of the possible enhancement of the efficacy of antituberculosis drugs by PheroidTM technology
… disease currently involves administration of a combination of rifampicin (R), isoniazid (H), pyrazinamide (Z) and ethambutol (E) for the initial 2 months, followed by rifampicin and isoniazid for 4 months. The World Health Organization (WHO) strongly encourages the use of fixed-dose combination …